help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on September 11, 2003, doi:10.1164/rccm.200306-731OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200306-731OCv1
168/12/1471    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ordoñez, C. L.
Right arrow Articles by Aitken, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ordoñez, C. L.
Right arrow Articles by Aitken, M. L.
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 1471-1475, (2003)
© 2003 American Thoracic Society

Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis

Claudia L. Ordoñez, Noreen R. Henig, Nicole Mayer-Hamblett, Frank J. Accurso, Jane L. Burns, James F. Chmiel, Cori L. Daines, Ronald L. Gibson, Sharon McNamara, George Z. Retsch-Bogart, Pamela L. Zeitlin and Moira L. Aitken

Departments of Pediatrics, Harvard Medical School, Boston, Massachusetts; University of Colorado School of Medicine, Denver, Colorado; Case Western Reserve University School of Medicine, Cleveland; University of Cincinnati College of Medicine, Cincinnati, Ohio; University of North Carolina, Chapel Hill, North Carolina; The Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Medicine, Stanford University School of Medicine, Stanford, California; and Departments of Pediatrics and Medicine, University of Washington, Seattle, Washington

Correspondence and requests for reprints should be addressed to Claudia L. Ordoñez, M.D., Children's Hospital, Division of Respiratory Diseases, 300 Longwood Avenue, Boston, MA 02215. E-mail: claudia.ordonez{at}tch.harvard.edu

Induced sputum has been used to study airway inflammation. We sought to determine whether markers of infection and inflammation in induced sputum were a useful and safe outcome measure in cystic fibrosis. We hypothesized that bacterial density and inflammatory content of induced sputum would decrease after antibiotic therapy. Induced sputum was assayed for bacterial density, cell count, and differential and inflammatory markers before and after treatment with intravenous antibiotics. Fifty-five of the 72 subjects enrolled (mean age ± SD 18.2 ± 7.9 years) completed the study. FEV1 increased by an average 0.3 ± 0.3 L (10.4 ± 8.7% predicted FEV1), p < 0.0001; density of Pseudomonas aeruginosa and Staphylococcus aureus decreased by 2.4 ± 3.1 log10 cfu/g (p < 0.0005) and 4.0 ± 2.3 log10 cfu/ml (p < 0.0001), respectively; neutrophil count decreased by 0.4 ± 0.6 log10 cells/ml (p < 0.0001), interleukin-8 concentration by 0.5 ± 1.3 log10 pg/ml (p < 0.05), and neutrophil elastase by 0.4 ± 0.7 log10 µg/ml (p < 0.005). Seven of 127 (6%) sputum induction procedures showed a decrease in FEV1 of 20% or more. We conclude that markers in induced sputum may be useful, noninvasive outcome measures to assess response to therapies in cystic fibrosis studies.

Key Words: cystic fibrosis • induced sputum • inflammatory markers • bacterial density




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. R. Esther Jr., G. Boysen, B. M. Olsen, L. B. Collins, A. J. Ghio, J. W. Swenberg, and R. C. Boucher
Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis
Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L987 - L993.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. Coote, H. C. Atherton-Watson, R. Sugar, A. Young, A. MacKenzie-Beevor, M. Gosling, G. Bhalay, G. Bloomfield, A. Dunstan, R. J. Bridges, et al.
Camostat Attenuates Airway Epithelial Sodium Channel Function in Vivo through the Inhibition of a Channel-Activating Protease
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 764 - 774.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. T. Saavedra, G. J. Hughes, L. A. Sanders, M. Carr, D. M. Rodman, C. D. Coldren, M. W. Geraci, S. D. Sagel, F. J. Accurso, J. West, et al.
Circulating RNA Transcripts Identify Therapeutic Response in Cystic Fibrosis Lung Disease
Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 929 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. M. Rowe, P. L. Jackson, G. Liu, M. Hardison, A. Livraghi, G. M. Solomon, D. B. McQuaid, B. D. Noerager, A. Gaggar, J. P. Clancy, et al.
Potential Role of High-Mobility Group Box 1 in Cystic Fibrosis Airway Disease
Am. J. Respir. Crit. Care Med., October 15, 2008; 178(8): 822 - 831.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Griese, M. Kappler, A. Gaggar, and D. Hartl
Inhibition of airway proteases in cystic fibrosis lung disease
Eur. Respir. J., September 1, 2008; 32(3): 783 - 795.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. R. Esther Jr, N. E. Alexis, M. L. Clas, E. R. Lazarowski, S. H. Donaldson, C. M. Pedrosa Ribeiro, C. G. Moore, S. D. Davis, and R. C. Boucher
Extracellular purines are biomarkers of neutrophilic airway inflammation
Eur. Respir. J., May 1, 2008; 31(5): 949 - 956.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Gaggar, P. L. Jackson, B. D. Noerager, P. J. O'Reilly, D. B. McQuaid, S. M. Rowe, J. P. Clancy, and J. E. Blalock
A Novel Proteolytic Cascade Generates an Extracellular Matrix-Derived Chemoattractant in Chronic Neutrophilic Inflammation
J. Immunol., April 15, 2008; 180(8): 5662 - 5669.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
H. Mussaffi, E. M. Fireman, M. Mei-Zahav, D. Prais, and H. Blau
Induced Sputum in the Very Young: A New Key to Infection and Inflammation
Chest, January 1, 2008; 133(1): 176 - 182.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Dovey, M. L. Aitken, J. Emerson, S. McNamara, D. A. Waltz, and R. L. Gibson
Oral Corticosteroid Therapy in Cystic Fibrosis Patients Hospitalized for Pulmonary Exacerbation: A Pilot Study
Chest, October 1, 2007; 132(4): 1212 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. D. Sagel, J. F. Chmiel, and M. W. Konstan
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Gaggar, Y. Li, N. Weathington, M. Winkler, M. Kong, P. Jackson, J. E. Blalock, and J. P. Clancy
Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L96 - L104.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. Mayer-Hamblett, M. L. Aitken, F. J. Accurso, R. A. Kronmal, M. W. Konstan, J. L. Burns, S. D. Sagel, and B. W. Ramsey
Association between Pulmonary Function and Sputum Biomarkers in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 822 - 828.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C. H Goss and J. L Burns
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Thorax, April 1, 2007; 62(4): 360 - 367.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
S Rao and J Grigg
New insights into pulmonary inflammation in cystic fibrosis.
Arch. Dis. Child., September 1, 2006; 91(9): 786 - 788.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Grasemann, R. Schwiertz, S. Matthiesen, K. Racke, and F. Ratjen
Increased Arginase Activity in Cystic Fibrosis Airways
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1523 - 1528.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. J. Sloane, R. A. Lindner, S. S. Prasad, L. T. Sebastian, S. K. Pedersen, M. Robinson, P. T. Bye, D. W. Nielson, and J. L. Harry
Proteomic Analysis of Sputum from Adults and Children with Cystic Fibrosis and from Control Subjects
Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1416 - 1426.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. M. Moskowitz, J. M. Foster, J. C. Emerson, R. L. Gibson, and J. L. Burns
Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection
J. Antimicrob. Chemother., November 1, 2005; 56(5): 879 - 886.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. A. Kamboures, D. R. Blake, D. M. Cooper, R. L. Newcomb, M. Barker, J. K. Larson, S. Meinardi, E. Nussbaum, and F. S. Rowland
Breath sulfides and pulmonary function in cystic fibrosis
PNAS, November 1, 2005; 102(44): 15762 - 15767.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. Xiao, Y.-P. Hsu, A. Ishizaka, T. Kirikae, and R. B. Moss
Sputum Cathelicidin, Urokinase Plasminogen Activation System Components, and Cytokines Discriminate Cystic Fibrosis, COPD, and Asthma Inflammation
Chest, October 1, 2005; 128(4): 2316 - 2326.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
T. Wagner, G. Soong, S. Sokol, L. Saiman, and A. Prince
Effects of Azithromycin on Clinical Isolates of Pseudomonas aeruginosa From Cystic Fibrosis Patients
Chest, August 1, 2005; 128(2): 912 - 919.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 277 - 287.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. S. Armstrong
In Celebration of Expectoration: Induced Sputum Indices as Outcome Measures in Cystic Fibrosis
Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1412 - 1413.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society 		  Red Transition